finder.com
US
AU
NZ
UK
CA
SG
More

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Tiziana Life Sciences stock

Own Tiziana Life Sciences stock in just a few minutes.

Jing Jun Ma
Jing Jun Ma
Fact checked
Buy Tiziana Life Sciences PLC (TLSA) Learn more

Tiziana Life Sciences PLC is a biotechnology business based in the US. Tiziana Life Sciences shares (TLSA) are listed on the NASDAQ and all prices are listed in US Dollars. Tiziana Life Sciences employs 8 staff and has a market cap (total outstanding shares value) of USD$309.9 million.

How to buy shares in Tiziana Life Sciences

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Tiziana Life Sciences. Find the stock by name or ticker symbol: TLSA. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Tiziana Life Sciences reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Tiziana Life Sciences, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Tiziana Life Sciences. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

What's in this guide?

  1. TLSA shares summary
  2. Compare share dealing platforms
  3. Is TLSA stock a buy or sell?
  4. Stock performance over time
  5. Can I short TLSA shares?
  6. Tiziana Life Sciences's financials
  7. How volatile are TLSA shares?
  8. Does Tiziana Life Sciences pay a dividend?
  9. Have TLSA shares ever split?
  10. Other common questions

Tiziana Life Sciences share price

Use our graph to track the performance of TLSA stocks over time.

Tiziana Life Sciences shares at a glance

Information last updated 2021-02-24.
52-week rangeUSD$0.6226 - USD$6.14
50-day moving average USD$3.6339
200-day moving average USD$3.4287
Wall St. target priceUSD$9.5
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-0.073

Buy Tiziana Life Sciences shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Robinhood
Robinhood
$0
Stocks, Options, ETFs, Gold/Commodities
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Go to site
More Info
Interactive Brokers
Interactive Brokers
$0
Stocks, Bonds, Options
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Go to site
More Info
Tastyworks
Tastyworks
$0
Stocks, Options, Cryptocurrency
Stocks & ETFs: $1/contract to open, $0 to close, $10 max/leg
Futures: $2.50/contract to open, $0 to close
0%
Get 100 shares of stock (worth $1 to $6 a share)
Open and fund a new cash or margin account with $2,000+
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Go to site
More Info
Moomoo
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
N/A
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
Go to site
More Info
TradeStation
TradeStation
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$50
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Go to site
More Info
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Tiziana Life Sciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Tiziana Life Sciences PLC by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Tiziana Life Sciences financials

Gross profit TTM USD$0
Return on assets TTM -82.38%
Return on equity TTM -804.99%
Profit margin 0%
Book value $-0.034
Market capitalisation USD$309.9 million

TTM: trailing 12 months

Shorting Tiziana Life Sciences shares

There are currently 221,711 Tiziana Life Sciences shares held short by investors – that's known as Tiziana Life Sciences's "short interest". This figure is 38.2% down from 358,852 last month.

There are a few different ways that this level of interest in shorting Tiziana Life Sciences shares can be evaluated.

Tiziana Life Sciences's "short interest ratio" (SIR)

Tiziana Life Sciences's "short interest ratio" (SIR) is the quantity of Tiziana Life Sciences shares currently shorted divided by the average quantity of Tiziana Life Sciences shares traded daily (recently around 2.0 million). Tiziana Life Sciences's SIR currently stands at 0.11. In other words for every 100,000 Tiziana Life Sciences shares traded daily on the market, roughly 110 shares are currently held short.

However Tiziana Life Sciences's short interest can also be evaluated against the total number of Tiziana Life Sciences shares, or, against the total number of tradable Tiziana Life Sciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Tiziana Life Sciences's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Tiziana Life Sciences shares in existence, roughly 0 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable Tiziana Life Sciences shares, roughly 0 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Tiziana Life Sciences.

Find out more about how you can short Tiziana Life Sciences stock.

Tiziana Life Sciences share dividends

We're not expecting Tiziana Life Sciences to pay a dividend over the next 12 months.

Have Tiziana Life Sciences's shares ever split?

Tiziana Life Sciences's shares were split on a 2499:1000 basis on 31 July 2020. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 2499 shares. This wouldn't directly have changed the overall worth of your Tiziana Life Sciences shares – just the quantity. However, indirectly, the new 60% lower share price could have impacted the market appetite for Tiziana Life Sciences shares which in turn could have impacted Tiziana Life Sciences's share price.

Tiziana Life Sciences share price volatility

Over the last 12 months, Tiziana Life Sciences's shares have ranged in value from as little as $0.6226 up to $6.14. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Tiziana Life Sciences's is 0.0239. This would suggest that Tiziana Life Sciences's shares are less volatile than average (for this exchange).

Tiziana Life Sciences overview

Tiziana Life Sciences Plc, a clinical stage biotechnology company, focuses on the discovery and development of molecules and related diagnostics to treat diseases in oncology and immunology in the United Kingdom. The company's product pipeline includes Foralumab (TZLS-401), a human anti-CD3 monclonal antibody for the treatment of autoimmune and inflammatory diseases, such GvHD, ulcerative colitis, Crohn's disease, multiple sclerosis, type-1 diabetes, inflammatory bowel diseases, psoriasis, and rheumatoid arthritis; and Milciclib (TZLS-201), which is an orally bioavailable, small molecule inhibitor of cyclin-dependent kinases and Src family kinases for the treatment of hepatocellular carcinoma. It also develops Anti IL-6r (TZLS-501), a human anti-interleukin-6 receptor monoclonal antibody for the treatment of IL6-induced inflammation, primarily to treat hospitalized COVID-19 patients with severe respiratory symptoms; and StemPrintER, a multi-gene signature assay intended for use in patients diagnosed with estrogen-receptor positive ER+/HER2 negative breast cancers. The company was founded in 2013 and is headquartered in London, the United Kingdom. Tiziana Life Sciences Plc is a subsidiary of Planwise Group Limited.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site